• Login
    • Login
    Advanced Search
    View Item 
    •   Maseno IR Home
    • Journal Articles
    • School of Medicine
    • Internal Medicine
    • View Item
    •   Maseno IR Home
    • Journal Articles
    • School of Medicine
    • Internal Medicine
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Epidemiology of Microbial Keratitis in Uganda: A Cohort Study

    Thumbnail
    View/Open
    09286586.2019 (1).pdf (1.833Mb)
    Publication Date
    2020
    Author
    Simon Arunga Guyguy M. Kintoki, James Mwesigye, Bosco Ayebazibwe, John Onyango, Joel Bazira, Rob Newton, Stephen Gichuhi, Astrid Leck, David Macleod, Victor H. Hu, and Matthew J. Burton
    Metadata
    Show full item record
    Abstract/Overview
    Purpose: To describe the epidemiology of Microbial Keratitis (MK) in Uganda. Methods: We prospectively recruited patients presenting with MK at two main eye units in Southern Uganda between December 2016 and March 2018. We collected information on clinical history and presentation, microbiology and 3-month outcomes. Poor vision was defined as vision < 6/60). Results: 313 individuals were enrolled. Median age was 47 years (range 18–96) and 174 (56%) were male. Median presentation time was 17 days from onset (IQR 8–32). Trauma was reported by 29% and use of Traditional Eye Medicine by 60%. Majority presented with severe infections (median infiltrate size 5.2 mm); 47% were blind in the affected eye (vision < 3/60). Microbiology was available from 270 cases: 62% were fungal, 7% mixed (bacterial and fungal), 7% bacterial and 24% no organism detected. At 3 months, 30% of the participants were blind in the affected eye, while 9% had lost their eye from the infection. Delayed presentation (overall p = .007) and prior use of Traditional Eye Medicine (aOR 1.58 [95% CI 1.04–2.42], p = .033) were responsible for poor presentation. Predictors of poor vision at 3 months were: baseline vision (aOR 2.98 [95%CI 2.12–4.19], p < .0001), infiltrate size (aOR 1.19 [95%CI 1.03–1.36], p < .020) and perforation at presentation (aOR 9.93 [95% CI 3.70–26.6], p < .0001). Conclusion: The most important outcome predictor was the state of the eye at presentation, facilitated by prior use of Traditional Eye Medicine and delayed presentation. In order to improve outcomes, we need effective early interventions.
    Permalink
    https://repository.maseno.ac.ke/handle/123456789/4376
    Collections
    • Internal Medicine [57]

    Related items

    Showing items related by title, author, creator and subject.

    • Thumbnail

      Traditional eye medicine use in microbial keratitis in Uganda: a mixed methods study 

      Simon Arunga , Allen Asiimwe , Eunice Apio Olet , Grace Kagoro-Rugunda , Bosco Ayebazibwe , John Onyango , Robert Newton , Astrid Leck , David Macleod , Victor H. Hu , Janet Seeley , Matthew J. Burton (The Wellcome Trust, 2019)
      Background: Traditional eye medicine (TEM) is frequently used to treat microbial keratitis (MK) in many parts of Africa. Few reports have suggested that this is associated with a worse outcome. We undertook this large ...
    • Thumbnail

      Risk Factors of Microbial Keratitis in Uganda: A Case Control Study 

      Simon Arunga, Guyguy M. Kintoki, Stephen Gichuhi, John Onyang, Bosco Ayebazibwe, Rob Newton, Astrid Leck, David Macleod, Victor H. Hu, and Matthew J. Burton (Taylor & Francis, 2020)
      Purpose: Microbial keratitis (MK), is a frequent cause of sight loss worldwide, particularly in low and middle-income countries. This study aimed to investigate the risk factors of MK in Uganda. Methods: Using a nested ...
    • Thumbnail

      The management of microbial keratitis within Uganda’s primary health system: a situational analysis 

      Simon Arunga , Naome Kyomugasho , Teddy Kwaga , John Onyango , Astrid Leck , David Macleod , Victor Hu , Matthew Burton (Wellcome Open Research, 2019)
      Background: Microbial keratitis (MK) frequently leads to sight-loss, especially when the infection is severe and/or appropriate treatment is delayed. The primary health system as an entry point plays a central role ...

    Maseno University. All rights reserved | Copyright © 2022 
    Contact Us | Send Feedback

     

     

    Browse

    All of Maseno IRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Maseno University. All rights reserved | Copyright © 2022 
    Contact Us | Send Feedback